This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170725006416/en/
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, Mass., Vertex's headquarters is now
located in Boston's
Vertex's Special Note Regarding Forward-looking Statements
This press release contains forward-looking statements as defined in the
Private Securities Litigation Reform Act of 1995, including, without
limitation, statements regarding potential milestone payments. While
Vertex believes the forward-looking statements contained in this press
release are accurate, these forward-looking statements represent the
company's beliefs only as of the date of this press release and there
are a number of factors that could cause actual events to differ
materially from those indicated by such forward-looking statements.
These risks and uncertainties include, among other things, the risks
listed under Risk Factors in Vertex's annual report and quarterly
reports filed with the
Concert's Cautionary Note on Forward-looking Statements
Any statements in this press release about our future expectations,
plans and prospects, including statements about the potential payments
to be received pursuant to the asset purchase agreement and other
statements containing the words "anticipate," "believe," "continue,"
"could," "estimate," "expect," "intend," "may," "plan," "potential,"
"predict," "project," "should," "target," "would," and similar
expressions, constitute forward-looking statements within the meaning of
The Private Securities Litigation Reform Act of 1995. Actual results may
differ materially from those indicated by such forward-looking
statements as a result of various important factors, including the
factors discussed in the "Risk Factors" section of our most recent
Quarterly Report on Form 10-Q filed with the
The Yates Network
News Provided by Acquire Media